UK Bans Puberty Blockers for Everyone Under 18 years of Age

by
Steve MacDonald

Last week, the world’s leading authority on transgender treatment and surgery was caught with its non-binary pants down. Internal documents proved they knew hormone therapy in children could lead to cancer or death. Three days of mourning later, the UK’s health ministry and the NHS have banned them.

No one under the age of 18 years can receive puberty blockers from public health services, with one exception: clinical trials.

Following a four-year study, while gender dysphoria diagnoses multiplied like crazed rabbits by over ten times, the UK’s National Health Service finally issued new rules Tuesday. Trans activists were shocked and appalled that the NHS completely prohibited prescriptions for puberty blockers for kids under 18 (apart from in approved clinical trials). On top of that, British lawmakers introduced a bill law week that would even ban the private sale of puberty drugs.

So, no—Schellnberger’s WPATH files did not drive the decision, but it seems like the announcement release date was. They invested four years in research and review and just happened to have planned public notice three days after the UK Telegraph covered the WPATH Files expose.

A week earlier on March 4th, Twitter-files journalist Michael Shellenberger published a new 242-page report he called the ‘WPATH Files.’  WPATH — the World Professional Association for Transgender Health — is the ‘premier’ global, pro-trans nonprofit. It publishes an influential ‘transgender standard of care’ that has been adopted by most Western governments and key licensing boards like the American Academy of Pediatrics.

The side effects of the WPATH files may be far-reaching. Other European nations have considered limitations or restrictions for minors, as have several states in the US, as Forbes notes, “despite opposition by organizations including the American Medical Association and American Academy of Pediatrics.” I wonder what will next be their basis for opposition. Follow the science? WPATH is (or was) the go-to authority, and they’ve admitted to significant health risks, including death. That the therapy is not the panacea advertised that transition surgeries are dangerous, mutilating and neutering the patients for life.

WPATH member surgeons cheerfully discussed Frankensteinian techniques on kids to create freakish and unnatural results, like keeping both sets of genitals (the “phallus-preserving vaginoplasty”), gruesome nipple-erasing mastectomies, and worst of all, a grotesque “nullification” surgery, leaving no genitals at all, neither real nor fake ones, just smooth skin.

And now the NHS has stepped up, after conducting four years of scientific research, to say we’re not giving these drugs to children. It’s not … safe or effective.

Talk about an awkward transition.

The game-changing significance of the UK ban might not be completely obvious at first. Surgeries are nearly always reserved for older children, and usually require kids to have been taking hormone for months or years before the invasive medical procedures. And if kids aren’t taking early puberty blockers, normal development can occur, which often resolves the gender confusion. Stopping early puberty blockers shuts down the railroad to surgery.

Some US States will rightly use these revelations to advance protections for children but don’t expect any movement nationally. The drugs and the surgeries are big business, and the Democrats, along with bureaucrats in the public health industrial complex, are keen to keep that laundromat open for business. It also abets both cultural division and depopulation agenda.

Besides, if harming a few children were of real concern, no one would have approved the COVID Jab for anyone under the age of eighteen.

Author

  • Steve MacDonald

    Steve is a long-time New Hampshire resident, blogger, and a member of the Board of directors of The 603 Alliance. He is the owner of Grok Media LLC and the Managing Editor of GraniteGrok.com, a former board member of the Republican Liberty Caucus of New Hampshire, and a past contributor to the Franklin Center for Public Policy.

Share to...